SOURCE: ZELTIQ Aesthetics, Inc.

ZELTIQ Aesthetics, Inc.

ZELTIQ Aesthetics, Inc.

June 27, 2016 09:00 ET

ZELTIQ® Announces Global Commercial Launch of the CoolAdvantage™ Applicator for the CoolSculpting® System

Innovative 3-in-1 Applicator Designed to Deliver Enhanced Patient Results

PLEASANTON, CA--(Marketwired - June 27, 2016) - ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that following an initial pilot phase, it has initiated the global commercial launch of the CoolAdvantage applicator. The CoolAdvantage applicator, which features an adaptable 3-in-1 configuration and enhanced cup design, reduces treatment time by nearly 50 percent due to advances in the CoolSculpting® technology, which enable treatments to be safely performed at a lower temperature.

"We are very proud to introduce the new CoolAdvantage applicator which reflects our ongoing commitment to research and innovation," said Mark Foley, President and Chief Executive Officer at ZELTIQ. "With the CoolAdvantage applicator, our CoolSculpting providers will be able to perform the CoolSculpting treatment in approximately half the time with greater patient comfort while increasing the amount of tissue that is in contact with the applicator. Collectively, we believe this is a major advance forward and will allow our practices to build on the proven clinical performance resulting from our over three million treatments performed to date."

CoolAdvantage is the third CoolSculpting applicator to utilize new treatment parameters based on clearance the company received last year from the Food and Drug Administration (FDA) to perform the CoolSculpting procedure at lower temperatures for shorter treatment times. It comes with three interchangeable contours, creating three distinct applicators to address multiple treatment areas on the patient:

  • CoolFit Advantage™ is ideal for vertical areas of fat such as the inner thigh.
  • CoolCore Advantage™ best matches the contours of the abdomen.
  • CoolCurve+ Advantage™ is the applicator of choice for flanks.

"With the introduction of the CoolAdvantage applicator, ZELTIQ is presenting providers an even greater return on their investment in the CoolSculpting system," said Dr. Scott Gerrish, Medical Director of Gerrish & Associates MedSpa, with locations in Vienna and Alexandria, Va., and Medical Director of ZELTIQ Training Center East. "One of my patients chose to have two extra treatments during the appointment because we had the ability to conduct simultaneous CoolSculpting treatments using our two systems. I ultimately performed six treatments in just one hour and forty-five minutes. This patient, who had CoolSculpting treatments in the past with other applicators, reported a marked improvement in comfort with the CoolAdvantage applicator."

The CoolSculpting procedure is FDA-cleared. It is available in the United States for the non-invasive treatment of visible fat bulges in the submental area, thigh, abdomen and flank, along with bra fat, back fat, and underneath the buttocks (also known as banana roll). In most other international markets, it is approved for general non-invasive fat reduction. The CoolSculpting procedure results in a noticeable and measurable reduction of fat in the treated areas, and the treated fat cells are gone for good. Most patients can start to see results as soon as three weeks following treatment, with the most dramatic results occurring over a period of one to three months. Every patient is unique, so patients are encouraged to talk to their physicians about a customized treatment plan as part of the initial consultation. Additional treatments in the same or multiple areas may enhance the desired aesthetic effect.

The CoolSculpting procedure is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at www.coolsculpting.com.

About the CoolSculpting® Procedure

The CoolSculpting procedure is a non-surgical, clinically proven procedure that selectively reduces unwanted fat using a patented cooling technology. The CoolSculpting procedure is cleared by the FDA. The CoolSculpting procedure works by gently cooling targeted fat cells in the body to induce a natural, controlled elimination of fat cell without affecting surrounding tissue, and the treated fat cells are gone for good. Millions of CoolSculpting treatments have been performed by nearly 5,000 CoolSculpting systems in over 70 countries. Market research indicates up to a 95 percent customer satisfaction rate with the CoolSculpting procedure. The CoolSculpting procedure is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at www.coolsculpting.com.

Be sure to follow CoolSculpting on Facebook, Twitter, Pinterest and YouTube.

About ZELTIQ® Aesthetics, Inc.

ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting system, is designed to selectively reduce unwanted fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.